HYDERABAD, India, June 30, 2026 /PRNewswire/ -- Shantha Biologics today announced that it has entered into an outsourcing agreement with Novo Nordisk to provide cartridge fill-finish manufacturing services in India.
Home
Immediapress
Pr Newswire
Comunicato stampa - contenuto promozionale
Responsabilità editoriale PrNewswire
Shantha Biologics partners with Novo Nordisk to provide cartridge fill-finish services for injectable medicines at its Hyderabad…
Shantha Biologics has secured a significant contract with Danish pharmaceutical giant Novo Nordisk to manufacture cartridges for…
Eighteen months after Novo Nordisk purchased a plant in the | Eighteen months after Novo Nordisk purchased a plant in the Czech…
OneSource Specialty Pharma partners with Formycon for biosimilar manufacturing, enhancing India's role in global biologics…
Shilpa Medicare Limited ha annunciato che la sua filiale totalmente controllata, Shilpa Biologicals Private Limited, ha…
OneSource Specialty Pharma has announced a manufacturing partnership for biosimilars with Formycon AG. This collaboration will…
